Clinical Outcomes and Safety of 25-Gauge Pars Plana Vitrectomy in Vitreous Haemorrhage

Authors

  • Arshad Mehmood Author
  • Saliha Naz Author
  • Fawad Rizvi Author
  • Zeeshan Kami Author
  • Sahira Wasim Author
  • Tanveer Hassan Khan Author

DOI:

https://doi.org/10.51985/

Keywords:

Vitreous Haemorrhage; Diabetic Retinopathy; Central Retinal Vein Occlusion (CRVO); Pars Plana Vitrectomy

Abstract

 ABSTRACT

 

Objectives: This study evaluates the outcomes of 25-gauge pars plana vitrectomy (25G PPV) for dense vitreous haemorrhage (VH) of diverse etiology

 

Study Design and Settings: This is a prospective interventional study in which 25G PPV was performed for dense VH at a tertiary eye care centre. Eligible cases were selected from surgical retina clinic.

 

Methodology: All the investigations to determine the cause of VH were performed. Preoperative best corrected visual acuity(BCVA) was measured and then 25G PPV was performed. All the surgeries were done by the same surgeon. BCVA measurements were performed at postoperative day 1(Day1), one-month(1M), and two-month(2M) visits. Visual outcome was categorized based on underlying cause of VH

 

Results: The mean patient age was 51.4 years, with proliferative diabetic retinopathy (40.8%) being the most common aetiology, followed by central retinal vein occlusion (CRVO) and ocular trauma. Surgical intervention resulted in a significant and sustained improvement in visual acuity at all postoperative intervals (p < 0.001), with a mean gain of 0.530 logMAR at the two-month endpoint. The magnitude of improvement varied by aetiology; eyes with CRVO demonstrated the largest mean gain (0.784 logMAR), while trauma cases showed modest recovery (0.317 logMAR). The procedure demonstrated a favourable safety profile, with an overall complication rate of 14.3%, primarily consisting of recurrent VH (8.2%).

 

Conclusion: These findings confirm that 25-gauge PPV is a highly effective and safe intervention for restoring visual function in patients with dense VH, with aetiology serving as a key determinant of the final visual outcome

 

Keywords: Vitreous Haemorrhage; Diabetic Retinopathy; Central Retinal Vein Occlusion (CRVO); Pars Plana Vitrectomy 

References

1. Spraul CW, Grossniklaus HE. Vitreous hemorrhage. Survey

of ophthalmology. 1997 Jul 1;42(1):3-9.. DOI: https://doi.org/

10.1016/s0039-6257(97)84041-6

2 . Kwon W, Freeman SA. Phagocytosis by the retinal pigment

epithelium: recognition, resolution, recycling. Frontiers in

immunology. 2020 Nov 13;11:604205. DOI: https://doi.org/

10.3389/fimmu.2020.604205

3. Campbell DG, Simmons RJ, Grant WM. Ghost cells as a

cause of glaucoma. Am J Ophthalmol. 1976;81(4):441–50.

DOI : https://doi.org/10.1016/0002-9394(76)90299-34. Machemer R. Pars plana vitrectomy. Removal of preretinal

membranes. Transactions. Section on Ophthalmology.

American Academy of Ophthalmology and Otolaryngology.

1976 May 1;81(3 Pt 1):420-5.

5. Fujii GY, De Juan E Jr, Humayun MS, et al. A new 25-gauge

instrument system for transconjunctival sutureless vitrectomy

surgery. Ophthalmology. 2002;109(10):1807–12. DOI:

https://doi.org/10.1016/s0161-6420(02)01179-x

6. Eckardt C, Paulo EB. Heads-up surgery for vitreoretinal

procedures: an experimental and clinical study. Retina. 2016

Jan 1;36(1):137-47. DOI:https://doi.org/10.1097

/iae.0000000000000689

7. Singh A, Stewart JM. 25-Gauge vitrectomy. Ophthalmol Clin

North Am. 2004;17(2):201–6. DOI: https://doi.org/

10.1159/000360448

8. Hayreh SS, Podhajsky PA, Zimmerman MB. Natural history

of visual outcome in central retinal vein occlusion.

Ophthalmology. 2011;118(1):119–33DOI: https://doi.org/

10.1016/j.ophtha.2010.04.019

9. Sarrafizadeh R, Hassan TS, Ruby AJ, et al. Incidence of retinal

detachment and visual outcome in eyes presenting with

posterior vitreous detachment and dense fundus-obscuring

vitreous hemorrhage. Ophthalmology. 2001;108(12):2273–8

DOI : https://doi.org/10.1016/s0161-6420(01)00822-3

10. Johnston PB. Traumatic retinal detachment. Br J Ophthalmol.

1991;75(1):18–21. DOI: https://doi.org/10.1136/bjo.75.1.18

11. Chen SN, Lian IeB, Wei YJ. Clinical outcomes and

complications of 25-gauge transconjunctival sutureless

vitrectomy for proliferative diabetic retinopathy. Eye (Lond).

2017;31(12):1700–6. DOI : https://doi.org/10.1159/000328407

12. Shimizu H, Nakashima H, Uchida E, Kato M, Koga T, Hattori

T. Outcomes of 25-gauge vitrectomy for vitreous hemorrhage

associated with proliferative diabetic retinopathy. Clin

Ophthalmol. 2019;13:1543–51. DOI: https://doi.org/10.1007/

s00417-010-1506-7

13. Oshima Y, Wakabayashi T, Sato T, Ohji M, Tano Y. A 27–gauge

instrument system for transconjunctival sutureless

microincision vitrectomy surgery. Ophthalmology.

2010;117(1):93-102. doi:10.1016/j.ophtha.2009.06.058

14. Sharma T, Fong A, Lai TY, Lee V, Das S, Lam D. Surgical

treatment for diabetic vitreoretinal diseases: a review. Clin

Exp Ophthalmol. 2016;44(4):340-54. doi:10.1111/ceo.12687

15. de Bustros S, Thompson JT, Michels RG, Rice TA. Vitrectomy

for progressive proliferative diabetic retinopathy. Arch

Ophthalmol. 1987;105(2):196-9. doi:10.1001/archopht. 1987.

01060020090033

16. Hayreh SS, Podhajsky PA, Zimmerman MB. Natural history

of visual outcome in central retinal vein occlusion.

Ophthalmology. 2011;118(1):119-33. doi:10.1016/j.ophtha.

2010.04.019

17. Sarrafizadeh R, Hassan TS, Ruby AJ, Williams GA, Garretson

BR, Capone Jr A, Trese MT, Margherio RR. Incidence of

retinal detachment and visual outcome in eyes presenting

with posterior vitreous separation and dense fundus-obscuring

vitreous hemorrhage. Ophthalmology. 2001;108(12):2273-8.

doi:10.1016/S0161-6420(01)00843-8

18. Johnston PB. Traumatic retinal detachment. Br J Ophthalmol.

1991;75(1):18-21. doi:10.1136/bjo.75.1.18

19. Shimizu H, Nakashima H, Uchida E, Kato M, Koga T, Hattori

T. Outcomes of 25-gauge vitrectomy for vitreous hemorrhage

associated with proliferative diabetic retinopathy. Clin

Ophthalmol. 2019;13:1543-1551. doi:10.2147/OPTH.S207840

20. Gupta OP, Weichel ED, Regillo CD, et al. Postoperative

complications associated with 25-gauge pars plana vitrectomy.

Ophthalmic Surg Lasers Imaging. 2007;38(4):270-275.

doi:10.3928/15428877-20070701-07

21. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for

neovascular age-related macular degeneration. N Engl J Med.

2006;355(14):1419-1431. doi:10.1056/NEJMoa054481

22. Johnston PB. Traumatic retinal detachment. Br J Ophthalmol.

1991;75(1):18-21. doi:10.1136/bjo.75.1.18

23. Gupta B, Wong R, Sivaprasad S, Williamson TH. Surgical

and visual outcome following 20-gauge vitrectomy in

proliferative diabetic retinopathy over a 10-year period:

evidence for change in practice. Eye (Lond). 2012;26(4):576-

582. doi:10.1038/eye.2011.348

24. Fujii GY, De Juan E Jr, Humayun MS, et al. Initial experience

using the transconjunctival sutureless vitrectomy system for

vitreoretinal surgery. Ophthalmology. 2002;109(10):1814-

1820. doi:10.1016/S0161-6420(02)01259-5

25. Shaikh Y, Elmariah H, Jones SM. Advanced vitreoretinal

surgery techniques for the treatment of complex vitreoretinal

diseases. Curr Opin Ophthalmol. 2018;29(3):212-217.

doi:10.1097/ICU.0000000000000464

Downloads

Published

2026-04-21

Issue

Section

Original Articles

How to Cite

Clinical Outcomes and Safety of 25-Gauge Pars Plana Vitrectomy in Vitreous Haemorrhage. (2026). Journal of Bahria University Medical and Dental College, 16(02), 576-582. https://doi.org/10.51985/

Similar Articles

You may also start an advanced similarity search for this article.